Chief Executive Officer
Pascal NEUVILLE is Chief Executive Officer and co-founder of Domain Therapeutics. Under his leadership the company signed multiple Pharma partnerships and attracted significant investments from top-tier European investors on its assets. Prior to co-founding Domain Therapeutics, he held several positions in biopharma companies, Faust Pharmaceuticals and Transgene (NASDAQ: TRGNF). Pascal is President of Axilum Robotics and member of the strategic committee of Defymed. He is also member of the investment committee of Strasbourg University TTO, SATT Conectus, and President of the regional Incubator Quest for Change. Pascal started his career as Assistant Professor at the University of Geneva, Switzerland. He holds a PhD in molecular biology from University of Strasbourg, France.